Online First »
The US Department of Veterans Affairs (VA) is asking physicians in private practices to ensure veterans are receiving timely care following the scandal that rocked the department earlier this year.
Under the recent law, The Veterans’ Access to Care Through Choice, Accountability and Transparency Act, the VA can enter into provider agreements with physicians in private practices to deliver care during the next 2 years to veterans who live far from a VA facility or those who cannot access care at a VA facility in a timely manner.
Online Exclusive »
According to a recent study from the National Health and Nutrition Examination Survey (NHANES), rising obesity rates are the greatest contributor to the increasing prevalence of type 2 diabetes in the United States, accounting for all of the increase in women and approximately half of the increase in men [Ann Intern Med. 2014; DOI:10.7326/M14-0286]. Specifically, body mass index (BMI) was the greatest contributor to type 2 diabetes, according to the study.
Cover Story »
San Francisco—In November 2013, the American College of Cardiology (ACC) and the American Heart Association (AHA) released new guidelines for treatment with lipids and recommended the use of statins for millions of more adults, including most patients with type 2 diabetes. This was the first update since the National Heart, Lung and Blood Institute (NHLBI) released its most recent Adult Treatment Panel guidelines in 2001, which were modified in 2004.
- Improving Men’s Health, Quality of Life, and Cost Outcomes: Evolving Treatment Strategies for Benign Prostatic Hyperplasia
- Building Better COPD Management Programs: Incorporating HEDIS Measures and Clinical Data
- Assessing the Cost/Benefit of Oral MS Therapies on Patient Health and Resource Utilization
- Incorporating HEDIS Measures and Newer Therapies to Improve COPD Treatment Adherence and Outcomes
- Translating Guidelines and Evidence on Newer Anticoagulants to Improved Clinical and Cost Outcomes in AF-Related Stroke
- Opportunities to Reduce the Clinical and Economic Burden of Hyponatremia: Clinical and Pharmacoeconomic Guidance for Managed Care